MDS-specific comorbidity index is useful to identify myelodysplastic patients who can have better outcome with 5-azacitidine

Haematologica. 2012 Feb;97(2):e2. doi: 10.3324/haematol.2011.059808.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Female
  • Humans
  • Male
  • Myelodysplastic Syndromes / epidemiology*